InvestorsHub Logo
Followers 2
Posts 188
Boards Moderated 0
Alias Born 01/18/2019

Re: SonamKapoor post# 198803

Thursday, 06/27/2019 4:25:31 PM

Thursday, June 27, 2019 4:25:31 PM

Post# of 425920
Hi Sonam,

Well thought out response. Not to be dismissive, but we have seen far too many small studies report an overestimated treatment effect to take any too seriously (except perhaps early CAR-T in b-cell lymphoma). We are ready and willing to publicly acknowledge EPA is a wonderfully effective “drug” at reducing risk of ASCVD, but must insist it comes from a robustly sized, adequate and well-controlled trial. We have yet to see any of those Japanese studies fit that category.

-MRC

...

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News